墨西哥四个不同大都市区腹主动脉瘤的患病率
在回顾CT超过200例的中心患病率为4.03%,少于200例的中心为4.63%(P=0.41);本中心55至64岁患者(共3889例)患病率为0.77%。
要点
- 回顾CT超过200例的中心患病率4.03%,少于200例的中心4.63%(P=0.41)。
- 本中心55至64岁患者(3889例)AAA患病率为0.77%。
核心结论
- 墨西哥AAA患病率与其他国际报道无差异;影像筛查可能代表降低动脉瘤相关死亡率的成本效益策略。
研究设计与样本
- 横断面多中心研究,在9家不同的学术机构开展。
- 系统回顾本中心(INCMNSZ)年龄≥55岁患者及其余机构年龄≥65岁患者的腹部CT。
- 在非动脉瘤性主动脉中于肠系膜上动脉(SMA)和肠系膜下动脉(IMA)水平测量腹主动脉直径,在发现的AAA中测量最大直径。
主要发现
- 墨西哥研究人群AAA患病率为3.08%(399例AAA患者)。
- 回顾CT超过200例的中心患病率为4.03%,少于200例的中心为4.63%(P=0.41)。
- 本中心(INCMNSZ)55至64岁患者(共3889例)患病率为0.77%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Epidemiological data on aneurysmal disease affecting the abdominal aorta in Latin American countries are limited. In our institution, the National Institute of Medical Sciences and Nutrition Salvador Zubiran (INCMNSZ), we have reported an Abdominal Aortic Aneurysm (AAA) prevalence of 3.26% in patients at risk from our Ultrasound (US) screening program. We aim to determine and compare the prevalence of undetected AAA in four different Metropolitan areas in Mexico to justify further US screening efforts. METHODS: A cross-sectional multicenter study was conducted in 9 different academic institutions. Abdominal Computed Tomographies (CT) from patients with age equal or greater than 55 years in our center (INCMNSZ), and in 65 year old patients and older in the remainder institutions were systematically reviewed. Abdominal aortic diameters were measured at the level of the superior (SMA) and inferior mesenteric arteries (IMA) in nonaneurysmal aortas and maximum diameters in the found AAA. Categorical data were analyzed by nonparametric statistic test at significance level (P < 0.05), the Pearson test was used to determine the correlation of age and aortic diameters. RESULTS: The cohort included a total of 12, 936 patients paired with respect gender (53% females, with a mean age of 69 years), the AAA prevalence found in the studied Mexican population was 3.08% (399 AAA patients). In centers where more than 200 CTs scans were reviewed, the prevalence was 4.03%, compared to the 4.63% found in centers with less than 200 studies (P = 0.41). In patients between the ages of 55 to 64 from INCMNSZ (3889 total), the prevalence was 0.77%, supporting the need of focused US-screening programs in individuals at the age of 65 and older in our country. CONCLUSIONS: The introduction of a national US Screening Program for the detection of AAA in Mexico represents a challenge in our current health system. This Multicenter initiative demonstrates that our AAA prevalence is not different to other international reports; imaging screening might represent cost-effective strategy for reduction of aneurysm-related mortality.
引用
- Hinojosa CA, Ibanez-Rodriguez JF, Serrato-Auld RC, et al. Prevalence of abdominal aortic aneurysms in four different metropolitan areas in Mexico. Ann Vasc Surg. 2022. PMID: 34995742. doi:10.1016/j.avsg.2021.12.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。